Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
Andreone
P
P
I Patologia Medica Università di Bologna, Italy.
Cursaro
C
C
Miniero
R
R
Stefanini
G F
GF
Sprovieri
G
G
Gasbarrini
G
G
D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D005189:False Positive Reactions; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D006509:Hepatitis B / Q000276:immunology*; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology*; D003699:Hepatitis D / Q000276:immunology*; D006801:Humans; D015151:Immunoblotting; D008108:Liver Diseases, Alcoholic / Q000276:immunology*; D012680:Sensitivity and Specificity; D016036:Seroepidemiologic Studies
D006508:Hepatitis Antibodies